Figure 1
From: Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach
The decline in FEV1 and Kco expressed as a % predicted is shown over time for a 43 year old female from the UK registry who stopped smoking after diagnosis in 2005.